Clinical Study of KN052 in Chinese Subjects With Advanced Solid Tumors

NCT05309512 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
15
Enrollment
INDUSTRY
Sponsor class

Stopped Based on the differentiated R\&D strategy, the sponsor applies for the termination of the project.

Conditions

Interventions

Sponsor

Jiangsu Alphamab Biopharmaceuticals Co., Ltd